Answers are grounded in this paper and cite their sources.
Mycophenolate mofetil (MM), an immunosuppressant used after organ transplantation, is also used for treatment of autoimmune myasthenia gravis (MG). A patient with generalized MG was effectively managed with MM but developed CNS lymphoma after 3 years of treatment. Primary CNS lymphoma regressed on withdrawal of MM. Despite minimal short-term side effects and apparent efficacy, chronic treatment of MG with MM may be associated with increased risk of lymphoproliferative disorders.
No takes yet. Share an insight, caveat, or question.
Vernino et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: